{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:51:33Z","timestamp":1793904693670,"version":"4.8.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.rpth.2024.102399","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T23:14:06Z","timestamp":1712186046000},"page":"102399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Navigating the challenges: a case report on managing a complicated postpartum course in type 3 von Willebrand disease with alloantibodies"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9082-1416","authenticated-orcid":false,"given":"Konrad","family":"van der Zwet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3251-8595","authenticated-orcid":false,"given":"Karin P.M.","family":"van Galen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek C.C.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-6613","authenticated-orcid":false,"given":"Kathelijn","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2762-6033","authenticated-orcid":false,"given":"Roger E.G.","family":"Schutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-5524","authenticated-orcid":false,"given":"Lize F.D.","family":"van Vulpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102399_bib1","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102399_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.rpth.2024.102399_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102399_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia A with inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102399_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102530","article-title":"The potential role of emicizumab prophylaxis in severe von Willebrand disease","volume":"87","author":"Barg","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.rpth.2024.102399_bib6","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1182\/bloodadvances.2019000656","article-title":"Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies","volume":"3","author":"Weyand","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102399_bib7","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1111\/hae.14209","article-title":"Effectiveness of emicizumab in preventing life-threatening bleeding complications in type 3 von Willebrand disease with inhibitors: a paediatric report","volume":"27","author":"Cefalo","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102399_bib8","doi-asserted-by":"crossref","first-page":"e913","DOI":"10.1016\/S2352-3026(23)00280-6","article-title":"Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study","volume":"10","author":"Tiede","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2024.102399_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/bjh.14805","article-title":"Management of pregnancy in type 3 von Willebrand disease with alloantibodies","volume":"182","author":"Scott","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102399_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1538-7836.2003.00009.x","article-title":"Multi-therapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease","volume":"1","author":"Boyer-Neumann","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102399_bib11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1160\/TH12-03-0136","article-title":"Management of delivery with FVIII\/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies","volume":"108","author":"Mart\u00edn-Salces","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102399_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100633","article-title":"Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: a systematic review","volume":"39","author":"Punt","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2024.102399_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2012.09.002","article-title":"Hemophilic arthropathy in patients with von Willebrand disease","volume":"26","author":"van Galen","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2024.102399_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/hae.14518","article-title":"Towards novel treatment options in von Willebrand disease","volume":"28","author":"Lenting","year":"2022","journal-title":"Haemophilia"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T03:07:02Z","timestamp":1717384022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2475037924000888"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102399","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the challenges: a case report on managing a complicated postpartum course in type 3 von Willebrand disease with alloantibodies","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102399"}}